HIGHLIGHTS
- who: Ribotype Moxifloxacin Resistance Nosocomial and colleagues from the UnivProfDr. F. Allerberger () · Dr., PD · , Vienna, Austria Paracelsus Medical University have published the article: (2015) 127:587-593, in the Journal: (JOURNAL)
- what: The aim of the study was to ascertain the frequency distribution of C. difficile ribotypes among C. difficile positive patients hospitalized in Austrian hospitals in 2012.
SUMMARY
Clostridium difficile is a major identifiable infectious cause of nosocomial diarrhea. Little is known about the current dominant ribotypes of C. difficile among the hospitalized patients in Austria. Clostridium difficile ribotypes in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.